Consolidated revenue rose 26.97% YoY to ₹475.82 Cr (up 8.91% QoQ from Q1's ₹436.88 Cr), and consolidated PAT came in at ₹74.84 Cr — up 120.7% QoQ from ₹33.91 Cr, and sharply higher than the ₹2.53 Cr the Group posted a year ago (a base so small the YoY percentage itself isn't a meaningful gauge). Standalone, which excludes the overseas subsidiaries, swung from a ₹6.60 Cr loss a year ago to a ₹51.15 Cr profit this quarter on revenue up 32.3% YoY to ₹306.53 Cr — a materially different trajectory from consolidated, which was already marginally profitable last year, so the two statements shouldn't be read as telling the same story this time. The real story is the margin bridge: consolidated net margin (PAT/total income) rose to 14.91% from 7.46% in Q1 and just 0.65% a year ago, while operating margin (EBITDA excluding other income, over revenue) jumped to 13.4% from 6.83% in Q1 and was actually slightly negative (-0.9%) in the year-ago quarter. The consolidated effective tax rate was a light 9.4% (₹7.75 Cr on ₹82.58 Cr PBT), helped by the foreign-tax mix; standalone paid zero tax, continuing to carry unabsorbed depreciation and losses with no deferred tax asset recognised (note 7). Management's FY26-close commentary pointed to "operating leverage" and "headroom for further margin improvement" in FY27 without quantitative targets — this quarter's inflection in OPM/NPM is consistent with, and arguably ahead of, that framing, so the print reads as a beat against the qualitative guidance on record. No formal brokerage consensus or Q2 preview for Amagi could be located in search, so the street comparison is unknown; coverage tied to the Q1 release had flagged a base-effect headwind to Q2 YoY revenue growth, and the 27% actual print suggests the underlying business absorbed that drag. The quarter also carried a cybersecurity disclosure — on October 22, 2026 the company notified CERT-In of a cyber extortion threat on an edge transmission site, with management's preliminary assessment indicating no material financial impact (standalone and consolidated note 8) — alongside a commercial win, with NDTV adopting Amagi's AdFlow Orchestrator for FAST/CTV monetization, one concrete data point behind the AI/ad-tech growth narrative management has been citing. The board was strengthened concurrently with results: Dr. Bhaskar Ghosh (former Accenture Chief Strategy & Innovation Officer) joins as an additional independent director, and CTO Srividhya Srinivasan is elevated to Whole-time Director, both subject to shareholder approval.

Indraprastha Medical Corporation Ltd announced that Mr. Shivakumar Pattabhiraman has completed his tenure as Managing Director, effective November 4, 2026. His reappointment for a two-year term from November 5, 2024, to November 4, 2026, had been approved by shareholders at the AGM on September 24, 2024. Consequently, he has also ceased to be a member of the Stakeholders Relationship Committee. This marks a significant management transition for the company.

Pajson Agro India Limited has announced a strategic acquisition of a 100% equity stake in Pacific Global FZCO, Dubai, for a total consideration of ₹354.52 crore, to be discharged entirely through a share swap. This acquisition of Pacific Global, which has a 60,000 MT cashew processing capacity in Côte d’Ivoire, marks Pajson Agro's transition from an India-based processor to a global, origin-integrated cashew platform. The combined processing capacity will increase to 1,13,000 MT. Pacific Global reported a turnover of AED 40.32 million (₹104.18 crore) for January-August 2026. The company's Board also approved the Pajson Agro Employee Stock Option Scheme 2026 (ESOS 2026) and an increase in authorized share capital.

Healthy Investments Ltd announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on November 05, 2026. A limited review report from the statutory auditors was also provided. The company operates in a single segment. Previous periods' figures have been re-grouped for comparison.

Bambino Agro Industries Limited has received an Administrative Warning Letter from the Securities and Exchange Board of India (SEBI) dated October 30, 2026, for non-compliance with Regulation 23(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company entered into material related party transactions with Ghanta Foods Private Limited, amounting to ₹59.57 crore in FY 2023-24 and ₹61.31 crore in FY 2024-25. These transactions exceeded the materiality threshold of 10% of the consolidated turnover. The SEBI noted that the resolutions approving these transactions were passed after counting votes from the promoter and promoter group, who are deemed related parties and thus barred from voting. SEBI has warned the company to improve its compliance standards to avoid future enforcement actions.

Anmol India Ltd has announced that its Board of Directors will convene on November 11, 2026, at 4:30 PM IST. The primary agenda item is to consider and approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The meeting will be held at the company's registered office. This announcement is made in compliance with Regulation 29 of the SEBI (LODR) Regulations, 2015.

Unijolly Investments Company Ltd announced that its Board of Directors, in a meeting held on November 05, 2026, approved the withdrawal of a re-classification application concerning Mrs. Shantha Prasad Challa. The company will proceed with the re-classification of the remaining outgoing promoters. Additionally, the Board approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2026, along with the Limited Review Report from the statutory auditors.